Gaugler B, Langlet C, Martin J M, Schmitt-Verhulst A M, Guimezanes A
Centre d'Immunologie, INSERM-CNRS de Marseille-Luminy, France.
Eur J Immunol. 1991 Oct;21(10):2581-9. doi: 10.1002/eji.1830211040.
In this study, we demonstrated that some V beta 6+, CD4+, Mls-1a-specific T cell clones had cytolytic activity when stimulated with anti-T cell receptor(TcR)/CD3 monoclonal antibodies (mAb), but not with targets expressing Mls-1a, although they produced lymphokines (interleukin 2 and interferon-gamma) in response to both types of stimuli. To examine the possibility that lack of cytolysis resulted from expression of the Mls-1a antigen on merely a fraction of splenic B blasts, we (a) used the B cell lymphoma LBB.3.4.16 and (b) measured esterase secretion which is generally concurrent with cytotoxic T lymphocyte (CTL) activity. The B cell lymphoma maximally stimulated the T cell clone for interferon-gamma production when responding and stimulating cells were incubated at a 1:1 ratio, but it was never killed by the Mls-1a-specific T cell clone unless TcR/CD3-specific mAb were added. Furthermore, a fivefold excess of the Mls-1a B cell lymphoma did not induce any secretion of esterase, which was observed only in the presence of the TcR/CD3-specific mAb. Comparison of the reactivity of two Mls-1a-specific T cell hybridomas expressing the same TcR at similar surface density, revealed both quantitative and qualitative differences between CD3-specific mAb and Mls stimulation of the hybridomas. A small quantitative difference in the sensitivity of hybridoma FJ22.5 to stimulation with V beta 6 or CD3-specific mAb resulted in a marked decrease in efficiency of stimulation by Mls-1a for interleukin 2 production and to inability to detect growth inhibition by Mls-expressing cells. A qualitative difference was observed when analyses of inositol phosphate production were performed under optimal conditions of stimulation of the highly responsive T cell hybridoma (FJ8.1): only stimulation with CD3-specific mAb, but not Mls-expressing cells, could induce detectable inositol phosphate production. Lack of cytolysis of Mls-1a class II-expressing B cells may have evolutionary significance in view of the recent mapping of Mls to mouse mammary tumor virus genes.
在本研究中,我们证明一些Vβ6 +、CD4 +、Mls-1a特异性T细胞克隆在用抗T细胞受体(TcR)/CD3单克隆抗体(mAb)刺激时具有细胞溶解活性,但在用表达Mls-1a的靶细胞刺激时则没有,尽管它们对两种刺激均产生淋巴因子(白细胞介素2和干扰素-γ)。为了研究缺乏细胞溶解作用是否是由于仅一部分脾B母细胞上表达Mls-1a抗原所致,我们(a)使用了B细胞淋巴瘤LBB.3.4.16,并且(b)测量了通常与细胞毒性T淋巴细胞(CTL)活性同时出现的酯酶分泌。当反应细胞和刺激细胞以1:1的比例孵育时,B细胞淋巴瘤最大程度地刺激T细胞克隆产生干扰素-γ,但除非加入TcR/CD3特异性mAb,否则它从未被Mls-1a特异性T细胞克隆杀死。此外,Mls-1a B细胞淋巴瘤过量五倍也不会诱导酯酶分泌,只有在存在TcR/CD3特异性mAb时才会观察到酯酶分泌。比较两个在相似表面密度表达相同TcR的Mls-1a特异性T细胞杂交瘤的反应性,发现CD3特异性mAb与杂交瘤的Mls刺激之间存在数量和质量上的差异。杂交瘤FJ22.5对Vβ6或CD3特异性mAb刺激的敏感性存在微小的数量差异,这导致Mls-1a刺激产生白细胞介素2的效率显著降低,并且无法检测到表达Mls的细胞对其生长的抑制作用。当在高反应性T细胞杂交瘤(FJ8.1)的最佳刺激条件下进行肌醇磷酸生成分析时,观察到了质量上的差异:只有用CD3特异性mAb刺激,而不是用表达Mls的细胞刺激,才能诱导可检测到的肌醇磷酸生成。鉴于最近将Mls定位到小鼠乳腺肿瘤病毒基因,Mls-1a II类表达B细胞缺乏细胞溶解作用可能具有进化意义。